(Post-pandemic Era)-Global The Veterinary Biologics Market Segment Research Report 2023

Report ID: 876476 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The Veterinary Biologics Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Veterinary Biologics Market by Value
      2.2.1 Global The Veterinary Biologics Revenue by Type
      2.2.2 Global The Veterinary Biologics Market by Value (%)
    2.3 Global The Veterinary Biologics Market by Production
      2.3.1 Global The Veterinary Biologics Production by Type
      2.3.2 Global The Veterinary Biologics Market by Production (%)

3. The Major Driver of The Veterinary Biologics Industry
    3.1 Historical & Forecast Global The Veterinary Biologics Demand
    3.2 Largest Application for The Veterinary Biologics (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Veterinary Biologics Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Veterinary Biologics Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Veterinary Biologics Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Veterinary Biologics Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Veterinary Biologics Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Veterinary Biologics Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Veterinary Biologics Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Veterinary Biologics Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Veterinary Biologics Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Veterinary Biologics Average Price Trend
    12.1 Market Price for Each Type of The Veterinary Biologics in US (2017-2021)
    12.2 Market Price for Each Type of The Veterinary Biologics in Europe (2017-2021)
    12.3 Market Price for Each Type of The Veterinary Biologics in China (2017-2021)
    12.4 Market Price for Each Type of The Veterinary Biologics in Japan (2017-2021)
    12.5 Market Price for Each Type of The Veterinary Biologics in India (2017-2021)
    12.6 Market Price for Each Type of The Veterinary Biologics in Korea (2017-2021)
    12.7 Market Price for Each Type of The Veterinary Biologics in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Veterinary Biologics Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Veterinary Biologics

14. The Veterinary Biologics Competitive Landscape
     14.1 Merck
        14.1.1 Merck Company Profiles
        14.1.2 Merck Product Introduction
        14.1.3 Merck The Veterinary Biologics Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 Yebio
        14.2.1 Yebio Company Profiles
        14.2.2 Yebio Product Introduction
        14.2.3 Yebio The Veterinary Biologics Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 Ceva
        14.3.1 Ceva Company Profiles
        14.3.2 Ceva Product Introduction
        14.3.3 Ceva The Veterinary Biologics Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 Zoetis
        14.4.1 Zoetis Company Profiles
        14.4.2 Zoetis Product Introduction
        14.4.3 Zoetis The Veterinary Biologics Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 Ringpu Biology
        14.5.1 Ringpu Biology Company Profiles
        14.5.2 Ringpu Biology Product Introduction
        14.5.3 Ringpu Biology The Veterinary Biologics Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 Boehringer Ingelheim
        14.6.1 Boehringer Ingelheim Company Profiles
        14.6.2 Boehringer Ingelheim Product Introduction
        14.6.3 Boehringer Ingelheim The Veterinary Biologics Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 WINSUN
        14.7.1 WINSUN Company Profiles
        14.7.2 WINSUN Product Introduction
        14.7.3 WINSUN The Veterinary Biologics Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 HVRI
        14.8.1 HVRI Company Profiles
        14.8.2 HVRI Product Introduction
        14.8.3 HVRI The Veterinary Biologics Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
     14.9 CAHIC
        14.9.1 CAHIC Company Profiles
        14.9.2 CAHIC Product Introduction
        14.9.3 CAHIC The Veterinary Biologics Sales, Revenue (2017-2021)
        14.9.4 Strategic initiatives
     14.10 DHN
        14.10.1 DHN Company Profiles
        14.10.2 DHN Product Introduction
        14.10.3 DHN The Veterinary Biologics Sales, Revenue (2017-2021)
        14.10.4 Strategic initiatives
     14.11 CAVAC
     14.12 Vaksindo
     14.13 Elanco/Eli Lilly
     14.14 Avimex Animal
     14.15 Kyoto Biken
     14.16 ChengDu Tecbond
     14.17 Virbac
     14.18 Bio-Labs
     14.19 FATRO
     14.20 Jinyu Bio-Technology
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Veterinary Biologics Industry (Volume)
    Figure 2. The Veterinary Biologics Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Veterinary Biologics Revenue in 2021
    Figure 5. US The Veterinary Biologics Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Veterinary Biologics Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Veterinary Biologics Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Veterinary Biologics Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Veterinary Biologics Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Veterinary Biologics Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Veterinary Biologics Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Veterinary Biologics Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Veterinary Biologics Production, by Type (K Unit) (2017-2027)
    Table 5. The Veterinary Biologics Demand (K Unit) by Application (2017-2027)
    Table 6. The Veterinary Biologics Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Veterinary Biologics Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. Merck Profiles
    Table 61. Merck The Veterinary Biologics Product Introduction
    Table 62. Merck The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. Merck Strategic initiatives
    Table 64. Yebio Profiles
    Table 65. Yebio The Veterinary Biologics Product Introduction
    Table 66. Yebio The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. Yebio Strategic initiatives
    Table 68. Ceva Profiles
    Table 69. Ceva The Veterinary Biologics Product Introduction
    Table 70. Ceva The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. Ceva Strategic initiatives
    Table 72. Zoetis Profiles
    Table 73. Zoetis The Veterinary Biologics Product Introduction
    Table 74. Zoetis The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. Zoetis Strategic initiatives
    Table 76. Ringpu Biology Profiles
    Table 77. Ringpu Biology The Veterinary Biologics Product Introduction
    Table 78. Ringpu Biology The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. Ringpu Biology Strategic initiatives
    Table 80. Boehringer Ingelheim Profiles
    Table 81. Boehringer Ingelheim The Veterinary Biologics Product Introduction
    Table 82. Boehringer Ingelheim The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. Boehringer Ingelheim Strategic initiatives
    Table 84. WINSUN Profiles
    Table 85. WINSUN The Veterinary Biologics Product Introduction
    Table 86. WINSUN The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. WINSUN Strategic initiatives
    Table 88. HVRI Profiles
    Table 89. HVRI The Veterinary Biologics Product Introduction
    Table 90. HVRI The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 91. HVRI Strategic initiatives
    Table 92. CAHIC Profiles
    Table 93. CAHIC The Veterinary Biologics Product Introduction
    Table 94. CAHIC The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 95. CAHIC Strategic initiatives
    Table 97. DHN Profiles
    Table 98. DHN The Veterinary Biologics Product Introduction
    Table 99. DHN The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 100. DHN Strategic initiatives
    Table 101. CAVAC Profiles
    Table 102. CAVAC The Veterinary Biologics Product Introduction
    Table 103. CAVAC The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 104. CAVAC Strategic initiatives
    Table 105. Vaksindo Profiles
    Table 106. Vaksindo The Veterinary Biologics Product Introduction
    Table 107. Vaksindo The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 108. Vaksindo Strategic initiatives
    Table 109. Elanco/Eli Lilly Profiles
    Table 110. Elanco/Eli Lilly The Veterinary Biologics Product Introduction
    Table 111. Elanco/Eli Lilly The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 112. Elanco/Eli Lilly Strategic initiatives
    Table 113. Avimex Animal Profiles
    Table 114. Avimex Animal The Veterinary Biologics Product Introduction
    Table 115. Avimex Animal The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 116. Avimex Animal Strategic initiatives
    Table 117. Kyoto Biken Profiles
    Table 118. Kyoto Biken The Veterinary Biologics Product Introduction
    Table 119. Kyoto Biken The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 120. Kyoto Biken Strategic initiatives
    Table 121. ChengDu Tecbond Profiles
    Table 122. ChengDu Tecbond The Veterinary Biologics Product Introduction
    Table 123. ChengDu Tecbond The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 124. ChengDu Tecbond Strategic initiatives
    Table 125. Virbac Profiles
    Table 126. Virbac The Veterinary Biologics Product Introduction
    Table 127. Virbac The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 128. Virbac Strategic initiatives
    Table 129. Bio-Labs Profiles
    Table 130. Bio-Labs The Veterinary Biologics Product Introduction
    Table 131. Bio-Labs The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 132. Bio-Labs Strategic initiatives
    Table 133. FATRO Profiles
    Table 134. FATRO The Veterinary Biologics Product Introduction
    Table 135. FATRO The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 136. FATRO Strategic initiatives
    Table 137. Jinyu Bio-Technology Profiles
    Table 138. Jinyu Bio-Technology The Veterinary Biologics Product Introduction
    Table 139. Jinyu Bio-Technology The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Veterinary Biologics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Veterinary Biologics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Veterinary Biologics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports